The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,296.00
Bid: 12,322.00
Ask: 12,324.00
Change: -108.00 (-0.87%)
Spread: 2.00 (0.016%)
Open: 12,334.00
High: 12,362.00
Low: 12,250.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks lower amid worries for health of US economy

Thu, 27th Apr 2023 09:05

(Alliance News) - Stock prices in London opened lower on Thursday, with the FTSE 100 failing to get a boost by positive first-quarter results from major constituents including Barclays and AstraZeneca.

Market sentiment was weighed by uncertainty about the trajectory for the US economy and the knock-on effect of this worldwide, amid concern around the US banking sector.

The FTSE 100 index opened down 13.51 points, or 0.2%, at 7,839.84. The FTSE 250 was down 49.78 points, or 0.3%, at 19,158.19, and the AIM All-Share was down 1.38 points, or 0.2%, at 820.46.

The Cboe UK 100 was down 0.1% at 784.48, the Cboe UK 250 was down 0.2% at 16,805.67, and the Cboe Small Companies was down 0.1% at 13,701.73.

In London, Barclays rose 3.0%, the best blue-chip performer in early morning trade, after it said all three of its businesses performed well in the first quarter of 2023, with high-quality income growth and double-digit returns.

The bank reported pretax profit of GBP2.60 billion, up from GBP2.23 billion a year prior. Total income amounted to GBP7.24 billion, up from GBP6.50 billion.

Barclays' return on tangible equity was 15.0%, compared with 11.5% in the same quarter a year prior. Its CET1 ratio was 13.6% at the end of March, down from 13.9% at the end of December.

The lender said it remains on track to deliver is 2023 targets, with all its performance metrics in line with or ahead of guidance at the first quarter.

Unilever shares climbed 1.7%.

The consumer goods firm noted broad-based growth across all its business groups and geographies in the first quarter of 2023. It reported turnover of EUR14.8 billion, representing a 7.0% increase against the previous year.

Looking forward, Unilever said it expects to deliver another year of strong underlying growth in 2023, with an improved volume performance compared to 2022. It now expects underlying sales growth for the full-year to be at least at the upper end of its range of 3% to 4%.

Unilever reported that underlying sales growth was 10.5% in the first quarter. This beat market consensus according to Bloomberg of 7.5%.

AstraZeneca added 1.3% after it said it made a "strong start" to 2023. The drug maker posted only a slight dip in first-quarter revenue, despite a decline in takings from Covid-19 medicines.

Revenue in the quarter totalled USD10.88 billion, down 4.5% from USD11.39 billion the previous year. AstraZeneca noted that when excluding the sales of Covid-19 medicines, revenue grew by 15% year-on-year.

Astra's pretax profit multiplied to USD2.26 billion from USD553 million.

J Sainsbury shares fell 0.4%

The supermarket chain reported a drop in annual profit, saying it has spent GBP560 million on keeping prices low for customers amid the cost of living crisis.

Sainsbury's reported that revenue in its financial year ended March 4 rose by 5.3% to GBP31.49 billion from GBP29.90 billion a year earlier. However, pretax profit plummeted by 62% to GBP327 million from GBP854 million.

In the FTSE 250, Howden Joinery fell 4.7%.

Howden reported that revenue in its UK depot was 0.2% lower than the prior year and 1.6% lower on a same depot basis, reflecting "very strong prior year revenue comparatives".

Meanwhile, depot revenue in the firm's international businesses increased by 16.8% in local currency, but was 3.8% lower on a same depot basis, compared to the equivalent periods last year.

Elsewhere in London, Petrofac dropped 6.7% as it reported lower revenue and a widened net loss in 2022.

The energy infrastructure services provider reported a net loss of USD310 million, widened from USD245 million the previous year. Its loss before interest, tax, depreciation and amortisation widened to USD138 million from USD86 million the year prior. Revenue fell to USD2.59 billion from USD3.03 billion.

Chief Executive Tareq Kawash said Petrofac's performance for 2022 was "severely impacted" by the challenges in the its legacy Engineering & Construction portfolio, which continued to feel the "direct and indirect" effects of pandemic delays.

Wall Street ended largely lower on Wednesday, with the Dow Jones Industrial Average down 0.7% and the S&P 500 down 0.4% but the tech-heavy Nasdaq Composite up 0.5%.

Technology stocks ended higher, following well-received earnings from Microsoft and Alphabet, while other blue-chips faltered as bank shares fell further, weighed down by fears of further turmoil in the sector.

Alphabet numbers were well received, although the stock slipped back 0.1% after opening higher. Shares in Microsoft rose 7.2% after it reported increased revenue and earnings in its financial third quarter, boosted by solid growth in its cloud division.

Facebook-owner Meta Platforms, which reported after the closing bell on Wednesday, also posted positive earnings. Shares in the firm rose 12% in after-hours trade in New York, as it reported better-than-expected revenue in the first quarter and issued positive guidance for the next three months.

Meanwhile, among US banks, Bank of America close down 1.4%, Wells Fargo down 2.7% and JPMorgan Chase down 1.8%.

This came as shares in First Republic slid a further 30% on Wednesday, after halving the day before, as regulators, big banks and potential bidders for its assets all held back from stepping in to help the embattled San Francisco lender.

"No one knows at this point what will happen to FRC, but we know that the FRC crisis gets investors to wonder whether the Federal Reserve will go ahead with next week's so-far-mostly-certain 25 basis point hike or not," said Ipek Ozkardeskaya, senior analyst at Swissquote Bank.

The US Federal Reserve will announce its interest rate decision on May 3.

The pound was quoted at USD1.2466 early on Thursday in London, lower compared to USD1.2472 at the close on Wednesday. The euro stood at USD1.1045, unchanged against USD1.1046.

Francesco Pesole at ING said the rally by the euro against the dollar over recent days is "testament" to how markets seem to favour the euro among other currencies in instances when the dollar falls on the back of Fed dovish repricing and US banking concerns.

This time last week, the euro traded around USD1.09.

In European equities on Thursday, the CAC 40 in Paris was flat, while the DAX 40 in Frankfurt was 0.2% lower.

The year is off to a stronger start than expected at Deutsche Bank, with first quarter pretax profit growing 12% to EUR1.85 billion. This is the highest quarterly profit result since 2013, the bank said.

In releasing its first quarter results, Germany's largest lender announced it wants to drive earnings even higher and so will find way to further cut costs.

The stock was 0.6% lower in Frankfurt on Thursday morning.

In Tokyo on Thursday, the Nikkei 225 index ended 0.2% higher.

The Bank of Japan decides on its monetary policy on Friday. You-Na Park-Heger, analyst at Commerzbank, said it will "no doubt" be interesting.

"First of all, it is the first meeting under the new BoJ governor Kazuo Ueda. Secondly, inflation remains at elevated levels: core inflation has even risen further in March. This gives renewed rise to the question whether the BoJ's ultra-expansionary monetary policy is still appropriate," Park-Heger said.

"For some time now there has been speculation on the market that the BoJ might move away from its expansionary monetary policy going forward. However, Ueda's recent comments give the impression that the BoJ might want to maintain the status quo for now."

Against the yen, the dollar was trading at JPY133.64, higher compared to JPY133.54.

In China, the Shanghai Composite closed up 0.7%, while the Hang Seng index in Hong Kong closed up 0.1%.

The S&P/ASX 200 in Sydney closed down 0.3%.

Brent oil was quoted at USD77.90 a barrel at early in London on Thursday, down from USD80.29 late Wednesday. Gold was quoted at USD2,001.05 an ounce, higher against USD1,995.53.

Still to come on Thursday's economic calendar, the US weekly unemployment claims report and US GDP data will be released at 1330 BST.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.